Similarly, we found that the expression patterns of MYC, BCL2, double expression of MYC and BCL2, p53, and CD5 were not associated with OS in patients with WR‐DLBCL, SN‐DLBCL, or LN‐DLBCL (Table S1). The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.